Protocol 4: degenerative disc disease and facet arthritis (advanced) Goal: Slow degenerative processes and support tissue quality in chronic spinal degeneration Peptides: BPC-157 : 500mcg twice daily ongoing GHK-Cu : 2mg daily for tissue regeneration KPV : 300mcg daily for anti-inflammatory effects Optional : TB-500 2mg weekly for systemic support Duration: Extended protocols, potentially cycling on and off Why this works: Degenerative conditions require ongoing support rather than acute treatment
Researchers have investigated tirzepatide in preclinical and clinical settings related to incretin signaling, glucose regulation, and energy balance
Daily use may support consistent energy production, recovery, and fat metabolism
Plus, it's rigorously tested to make sure it's safe and potent
That is not evidence that CagriSema is safer only that it has not been through the labeling process
If cloudiness persists, allow vial to rest for 5-10 minutes and gently swirl again